(Q33997207)

English

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951 (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

phase III clinical trial

0 references

non-Hodgkin lymphoma

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

Barbara De Moerloose

1

object named as

Barbara De Moerloose

0 references

Brigitte Nelken

0 references

2

object named as

Stefan Suciu

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

ORCID Public Data File 2021

Françoise Mazingue

4

object named as

Françoise Mazingue

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Karima Yakouben

7

object named as

Karima Yakouben

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

11

object named as

Martine Munzer

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Patrick Boutard

14

object named as

Patrick Boutard

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Pierre Philippet

17

object named as

Pierre Philippet

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

18

object named as

Liliana Baila

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Yves Bertrand

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Alain Robert

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Anne Uyttebroeck

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Alice Ferster

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Geneviève Margueritte

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Patrick Lutz

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Nicolas Sirvent

12

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Lucilia Norton

13

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dominique Plantaz

15

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Frederic Millot

16

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Yves Benoit

19

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Jacques Otten

20

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Children's Leukemia Group of the European Organisation for Research and Treatment of Cancer (EORTC)

21

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

20 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

116

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

36-44

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Current management and challenges of malignant disease in the CNS in paediatric leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904579

5 July 2018

Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904579

5 July 2018

Reporting results of cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904579

5 July 2018

Chemotherapy of acute lymphocytic leukemia of childhood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904579

5 July 2018

More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904579

5 July 2018

Results and significance of six randomized trials in four consecutive ALL-BFM studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904579

5 July 2018

Lower incidence of meningeal leukemia when prednisone is replaced by dexamethasone in the treatment of acute lymphocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904579

5 July 2018

Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904579

5 July 2018

Importance of 6-mercaptopurine dose in lymphoblastic leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904579

5 July 2018

Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904579

29 October 2018

Dexamethasone in the maintenance phase of acute lymphoblastic leukaemia treatment: is the risk of lethal infections too high?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904579

29 October 2018

Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904579

29 October 2018

Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904579

29 October 2018

Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report. Children Leukemia Cooperative Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904579

29 October 2018

Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904579

29 October 2018

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2904579

29 October 2018

Duration and intensity of maintenance chemotherapy in acute lymphoblastic leukaemia: overview of 42 trials involving 12 000 randomised children

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results of Dana-Farber Cancer Institute Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1981-1995)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Avascular femoral head necrosis in pediatric cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20407035

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1182/BLOOD-2009-10-247965

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33997207&oldid=1916980925"